Systemic cannabinoids produce CB1-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT7 and 5-HT2A receptors

References

Page 1

	Year	Citations
Ethical guidelines for investigations of experimental pain in conscious animals M. Zimmermann Pain Pain TherapyPain SyndromeBehavioral SciencesHealth SciencesPain Medicine	1983	7.7K
Intrathecal morphine in mice: A new technique Janice L.K. Hylden, George L. Wilcox European Journal of Pharmacology AddictionMedicineNeuropharmacologyAddiction MedicinePain Management	1980	1.9K
The origin of descending pathways in the dorsolateral funiculus of the spinal cord of the cat and rat: Further studies on the anatomy of pain modulation Allan I. Basbaum, Howard L. Fields The Journal of Comparative Neurology Pain MedicineDorsolateral FuniculusComparative AnatomySpinal DisorderPeripheral Nervous System	1979	634
A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635 Elaine A. Forster, Ian A. Cliffe, David J. Bill, European Journal of Pharmacology Molecular PharmacologyBiochemistryFunctional SelectivityMedicineMechanism Of Action	1995	609
An analgesia circuit activated by cannabinoids Ian D. Meng, Barton H. Manning, William J. Martin, Nature Cannabis UseHealth SciencesAddictionPain MedicineMedicine	1998	411
Synthesis and Characterization of Potent and Selective Agonists of the Neuronal Cannabinoid Receptor (CB1) Cecilia J. Hillard, Sukumar Manna, Marcie J. Greenberg, Journal of Pharmacology and Experimental Therapeutics	1999	372
Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex Francis Rodriguez Bambico, Noam Katz, Guy Debonnel, Journal of Neuroscience	2007	324
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy Kenneth J. Valenzano, Laykea Tafesse, Gary Lee, Neuropharmacology Cannabis UseMolecular PharmacologyPain ResearchHealth SciencesFunctional Selectivity	2005	282
Characterization of SB‐269970‐A, a selective 5‐HT<sub>7</sub> receptor antagonist Jim J. Hagan, Gary Price, Nigel Deeks, British Journal of Pharmacology	2000	281
A Novel, Potent, and Selective 5-HT<sub>7</sub>Antagonist: (<i>R</i>)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970) Peter J. Lovell, Steven M. Bromidge, Steven Dabbs, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceTranslational PharmacologyBiochemistry	2000	248

Page 1